ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice

Meng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*广州中医药大学
International Immunopharmacology2022-10DOI: 10.1016/j.intimp.2022.109099
9被引24阅读
引用收藏
分享

摘要

Non-alcoholic fatty liver disease (NAFLD) has high occurrence in the global world, which poses serious threats to human health. Salvianolic acid B (SalB), an extract of the root of Salvia miltiorrhiza, has the protective effect on metabolic homeostasis. However, the mechanism is still unknown. In this study, we used ob/ob mice, a model of NAFLD, to explore the hepatoprotective effects of SalB. The results showed that SalB significantly reduced the body weights and liver weights, and ameliorated plasma alanine aminotransferase (ALT), aspartate amino-transferase (AST), triglyceride (TG), hepatic free fatty acid (FFA), total cholesterol (TC) levels, and hepatic TG and TC levels in ob/ob mice. SalB reduced the number of lipid droplets and inhibited hepatic lipogenesis by regulating peroxisome proliferator-activated receptor gamma (PPAR gamma), fatty acid synthase (FASN), stearoyl-Co A desaturase 1 (SCD1), and cluster of differentiation 36 (CD36). Compared to ob/ob mice, the lower expressions of the pro-inflammatory cytokines, such as interleukin-18 (IL-18), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and F4/80, were observed after SalB treatment. Importantly, SalB treatment inhibited the activation of NLRP3 inflammasome and reduced the severity of liver inflammation. Our findings suggested that SalB improved NAFLD pathology in ob/ob mice by reducing hepatic lipid accumulation and NLRP3 inflammasome activation, which might be the potential hepatoprotective mechanism of SalB.

学科与关键词

关键词
NAFLDSalBLipid metabolismNLRP3 inflammasome
相关
加载中…
  • Nobiletin mitigates NAFLD via lipophagy and inflammation
    Yang, Xushan; Deng, Yudi; Tu, Yali; Feng, Dongliang; Liao, Wenzhen*Food & Function, 2022, 13(19): 10186-10199.被引 6
  • NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
    Wang, Xianfei; Sun, Kangyue; Zhou, Youlian; Wang, Hong; Zhou, Yongjian; Liu, Side; Nie, Yuqiang*; Li, Yue*Biochemical and Biophysical Research Communications, 2021, 534: 734-739.被引 28
  • Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-KB signaling pathway
    Tian-qi, Chen; Yan-fang, Deng; Yan-yan, Wang*; Yong-hui, Zhang*Biochemical and Biophysical Research Communications, 2022, 626: 167-174.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2022-10
卷期
第 111 卷
页码
109099
DOI
10.1016/j.intimp.2022.109099
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Administration of Traditional Chinese Medicine of Guangdong Province [20211179]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]

作者

  • M

    Meng, Ling-Cui (第一作者)

    2 · guangzhou univ chinese med

  • Z

    Zheng, Jia-Yi

    2 · guangzhou univ chinese med

查看全部 8 位作者收起作者
  • Q

    Qiu, Yu-Hui

    2 · guangzhou univ chinese med

  • Z

    Zheng, Li

  • Z

    Zheng, Jue-Yan

  • L

    Liu, Yu-Qing

  • M

    Miao, Xiao-Lu (通讯)

  • L

    Lu, Xin-Yi (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417